How does erythromycin affect exposure to dienogest?

Erythromycin, a moderate CYP3A4 inhibitor, increased dienogest exposure (AUC over 24 hours) at steady state by 1.6-fold when coadministered, although the clinical relevance of potential interactions with enzyme inhibitors remains unknown.